Jose Maria Lopez-Picazo
Overview
Explore the profile of Jose Maria Lopez-Picazo including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
23
Citations
326
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Garcia-Consuegra A, Gimeno-Morales M, Cambeiro M, Lopez-Picazo J, Alcalde J, I Ramos L, et al.
Head Neck
. 2025 Mar;
PMID: 40062517
Background And Purpose: Full-dose postoperative external beam radiation therapy (EBRT)/chemoradiation is the standard of care in patients with resected, unirradiated head and neck cancer (HNC). This study aims to determine...
2.
Valencia K, Echepare M, Teijeira A, Pasquier A, Bertolo C, Sainz C, et al.
J Exp Med
. 2022 Sep;
219(12).
PMID: 36169652
Lung cancer remains the leading cause of cancer-related death worldwide. We identify DSTYK, a dual serine/threonine and tyrosine non-receptor protein kinase, as a novel actionable target altered in non-small cell...
3.
Ortiz-Espinosa S, Morales X, Senent Y, Alignani D, Tavira B, Macaya I, et al.
Cancer Lett
. 2021 Dec;
529:70-84.
PMID: 34971753
Myeloid-derived suppressor cells (MDSCs) play a major role in cancer progression. In this study, we investigated the mechanisms by which complement C5a increases the capacity of polymorphonuclear MDSCs (PMN-MDSCs) to...
4.
Figueroa R, Alfonso A, Marcos M, Lopez-Picazo J, Garcia-Mouriz A, Gil-Bazo I, et al.
TH Open
. 2019 Jul;
3(2):e153-e156.
PMID: 31259297
No abstract available.
5.
Fusco J, Pita G, Pajares M, Andueza M, Patino-Garcia A, de-Torres J, et al.
Cancer Med
. 2018 May;
7(7):3474-3483.
PMID: 29766673
Single nucleotide polymorphisms (SNPs) may modulate individual susceptibility to carcinogens. We designed a genome-wide association study to characterize individuals presenting extreme phenotypes of high and low risk to develop tobacco-induced...
6.
Castanon E, Soltermann A, Lopez I, Roman M, Ecay M, Collantes M, et al.
Cancer Lett
. 2017 May;
402:43-51.
PMID: 28549790
Id1 promotes carcinogenesis and metastasis, and predicts prognosis of non-small cell lung cancer (NSCLC)-adenocarcionoma patients. We hypothesized that Id1 may play a critical role in lung cancer colonization of the...
7.
Caicedo C, Garcia-Velloso M, Dolores Lozano M, Labiano T, Diaz C, Lopez-Picazo J, et al.
Eur J Nucl Med Mol Imaging
. 2014 Jul;
41(11):2058-65.
PMID: 24990403
Purpose: The tumour molecular profile predicts the activity of epidermal growth factor receptor (EGFR) inhibitors in non-small-cell lung cancer (NSCLC). However, tissue availability and tumour heterogeneity limit its assessment. We...
8.
Sadaba B, Del Barrio A, Campanero M, Azanza J, Gomez-Guiu A, Lopez-Picazo J, et al.
PLoS One
. 2014 Mar;
9(2):e89747.
PMID: 24587006
Background: Palonosetron is a potent second generation 5- hydroxytryptamine-3 selective antagonist which can be administered by either intravenous (IV) or oral routes, but subcutaneous (SC) administration of palonosetron has never...
9.
Prior C, Perez-Gracia J, Garcia-Donas J, Rodriguez-Antona C, Guruceaga E, Esteban E, et al.
PLoS One
. 2014 Jan;
9(1):e86263.
PMID: 24475095
Purpose: To identify tissue microRNAs predictive of sunitinib activity in patients with metastatic renal-cell-carcinoma (MRCC) and to evaluate in vitro their mechanism of action in sunitinib resistance. Methods: We screened...
10.
Castanon E, Bosch-Barrera J, Lopez I, Collado V, Moreno M, Lopez-Picazo J, et al.
J Transl Med
. 2013 Jan;
11:13.
PMID: 23311395
Background: Inhibitor of DNA binding 1 (Id1) and 3 (Id3) genes have been related with the inhibition of cell differentiation, cell growth promotion and tumor metastasis. Recently, Id1 has been...